Exploring the potential
of psychedelics for
the betterment of all.

Psychedelics 101

What are psychedelics?

Our primer on classic and non-classic psychedelic substances, including psilocybin, LSD, ketamine, and more.

What are the risks? Ask experts.

How should you choose a psychedelic therapist? What do “set and setting” mean? How should a trip sitter prepare for the experience? Experts answer these questions and more.

Microdosing—does it work?

Interest in psychedelics is growing fast, but legal use—either through a clinical trial or psychedelic therapy—can be complicated.

Psychedelics and Spirituality

People have used psychedelics to commune with the divine and create bonds among the living and the dead, the spiritual and the natural worlds for centuries and possibly millennia.

About BCSP

Psychedelic Research

We bring together researchers from across disciplines, including neuroscience, molecular biology, psychology, chemistry, and genetics, and experts in public policy, law, health economics, and religion.

Certificate Program in Psychedelic Facilitation

BCSP is training the next generation of psychedelic guides in a new program focused on interdisciplinary training for religious, spiritual-care, and health-care professionals.

Journalism and Public Education

BCSP’s public education program produces evidence-based, objective journalism, conversations, and courses about psychedelics.

Diversity, Equity, Inclusion, and Reciprocity

In our work, BCSP prioritizes the values of diversity, equity, and inclusion. We also strive to honor the Indigenous principle of reciprocity.

Professor Trujillo’s Vision for the Future of Psychedelic Education Produces First-Ever Graduates

As psychedelics gain traction in health care and community settings, comprehensive education is needed for care professionals and recipients alike.

UC Berkeley Center for the Science of Psychedelics Launches Online Course on Psychedelics and the Mind

The course, now available for free on edX, is the first globally-accessible comprehensive deep dive into psychedelics from the world’s foremost public university, on behalf of BCSP, a leading multi-disciplinary psychedelics research organization.

UC Berkeley Center for the Science of Psychedelics Unveils Results of the First-Ever Berkeley Psychedelics Survey

More than six out of ten (61%) American registered voters support legalizing regulated therapeutic access to psychedelics, including 35% who report “strong” support, the inaugural UC Berkeley Psychedelics Survey has found.

New National Poll: More Than 60 Percent of U.S. Voters Support Legalizing Psychedelic Therapy

BCSP previews results from the first-ever Berkeley Psychedelics Survey, a new national benchmark poll tracking public perceptions and attitudes about psychedelics.

Tools and Resources

Patent Tracker

BCSP has created a patent tracker that uses publicly available data gathered by Psychedelic Alpha, an independent community working in the psychedelic space.

Resources Database

We’ve combed through scientific papers, books, websites, popular articles and more to amass some of the top resources about therapy, neuroscience, risk reduction, microdosing, spirituality, and individual substances like psilocybin and MDMA.

Clinical Trials Map

In the United States, most psychedelic substances are illegal under federal law but states and municipalities are passing new laws to “decriminalize” them. What does that mean for how psychedelics are regulated?

Coming soon!

Law & Policy Map

Interest in psychedelics is growing fast, but legal use—either through a clinical trial or psychedelic therapy—can be complicated.

Coming soon!